Julia Lee from Burman Invest, Jun Bei Liu from Tribeca and Paul Rickard from Switzer join the show.

Peter Switzer speaks to Joe Oliver, the co-founder and Managing Director of Delorean (DEL).

The parameters of ageing can be reversed through the use of GlyNAC as shown through studies involving 8 elderly individuals compared with young adults.

Raymond Chan from Morgans, Gemma Dale from nabtrade, Jeremy Ng from Gemini, Ying Yi Ann Cheng from the Switzer Higher Yield Fund and Paul Rickard join this episode.

Join Peter Switzer and Paul Rickard for their weekly take on the latest money news.

Peter Switzer is joined by Julia Lee, Adam Dawes, Michael Knox and Paul Rickard on this episode of Switzer Investing.

Peter Switzer is joined by Andreas Fouras, the Managing Director, CEO and CTO of 4DMedical (4DX).

Dr Ross Walker talks about why it's beneficial for us to have B3 from pre cradle to grave as shown via results with clinical tests including rats.

On this week's show, Peter Switzer is joined by Michael Gable from Fairmont Equities, Marcus Bogdan from the Switzer Dividend Growth Fund, Simon Pressley from Propertyology and Ying Yi Ann Cheng from Coolabah Capital.

Catch up on all the latest money and markets news and find out how it affects you!

Peter Switzer sits down with the CEO and Managing Director of Actinogen Medical (ACW), Dr Steven Gourlay.

Dr Ross Walker discusses the decline of our body after the age of 30 and reversing the aging process.